Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

NCT02839694 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Neoplasm Metastasis
Sarcoma
Neoplasms, Germ Cell and Embryonal
Melanoma

Interventions

DRUG: decitabine (DAC)
DRUG: Tetrahydrouridine (THU)
DRUG: Celecoxib

Sponsor

National Cancer Institute (NCI)